TheStreet.com |
Galena Sacks CEO Amid Escalating Criminal Probe Into Fentanyl Drug Marketing
TheStreet.com The Feds are investigating Galena's marketing and promotional practices for Abstral, the company's fentanyl-based painkiller, according to an 8-K filing with the Securities and Exchange Commission. Schwartz was instrumental in Galena acquiring Abstral ... |
January 31, 2017 at 08:33PM | marketing - Google News
Galena Sacks CEO Amid Escalating Criminal Probe Into Fentanyl Drug Marketing - TheStreet.com
marketing - Google News
Nenhum comentário:
Postar um comentário